Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and characterization of ceramic-polymeric hybrid scaffolds for bone regeneration: incorporating of bioactive glass BG-58S into PDLLA matrix.
Aguiar VCPF, Bezerra RDN, Dos Santos KW, Gonçalves IDS, Costa KJSG, Lauda DP, Campos TMB, do Prado RF, de Vasconcellos LMR, de Oliveira IR. Aguiar VCPF, et al. Among authors: do prado rf. J Biomater Sci Polym Ed. 2024 Apr 3:1-18. doi: 10.1080/09205063.2024.2334981. Online ahead of print. J Biomater Sci Polym Ed. 2024. PMID: 38569077
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Effect of the nanofilm-coated zirconia ceramic on resin cement bond strength.
de Figueiredo VMG, Silva AM, Massi M, da Silva Sobrinho AS, de Queiroz JRC, Machado JPB, do Prado RF, Junior LN. de Figueiredo VMG, et al. Among authors: do prado rf. J Dent Res Dent Clin Dent Prospects. 2022 Summer;16(3):170-178. doi: 10.34172/joddd.2022.029. Epub 2022 Nov 15. J Dent Res Dent Clin Dent Prospects. 2022. PMID: 36704190 Free PMC article.
59 results